InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
7
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hernandez Marlow, PDG. Officer active across 1 company, notably Cano Health, Inc.. Cumulatively, 17 disclosures have been published. Split: 7 buys · 0 sell. Total volume traded: €2m. History available since 16 August 2021. The latest transaction was disclosed on 3 January 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hernandez Marlow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
189,681 sharesClass A Common StockSEC:0001209191-23-042327:0
671,742 sharesClass A Common StockSEC:0000950170-23-026059:0
348,604 sharesClass A Common StockSEC:0000899243-23-010565:0
134,660 shares@ US$0.8671.7% of flowClass A Common StockSEC:0000899243-23-000963:0
11,017,311 shares0Class A Common StockSEC:0000899243-22-039535:0
29,870 shares@ US$3.521.6% of flowClass A Common StockSEC:0000899243-22-025682:0
11,017,311 shares0Class A Common StockSEC:0000899243-22-020172:0
624,418 sharesClass A Common StockSEC:0000899243-22-011466:0
15,000 shares@ US$8.004.8% of flowClass A Common StockSEC:0000899243-21-047185:0
Canonical exit: 6 Mar 2022 (T+90)
12,500 shares@ US$8.754.3% of flowClass A Common StockSEC:0000899243-21-046941:0
Canonical exit: 3 Mar 2022 (T+90)
8,000 shares@ US$9.653.1% of flowClass A Common StockSEC:0000899243-21-046067:0
Canonical exit: 20 Feb 2022 (T+90)
1,339,500 sharesClass A Common StockSEC:0000899243-21-037547:0
5,833 shares@ US$11.992.7% of flowClass A Common StockSEC:0000899243-21-034907:0
Canonical exit: 29 Nov 2021 (T+90)
54,727 shares@ US$11.9324.8% of flowClass A Common StockSEC:0000899243-21-034612:0
Canonical exit: 23 Nov 2021 (T+90)
120,000 shares@ US$10.1616.9% of flowClass A Common StockSEC:0000899243-21-033876:0
Canonical exit: 14 Nov 2021 (T+90)
11,900 shares@ US$9.824.5% of flowClass A Common StockSEC:0000899243-21-033963:0
Canonical exit: 16 Nov 2021 (T+90)
120,000 shares@ US$10.1646.4% of flowClass A Common StockSEC:0000899243-21-033441:0
17 of 17 declarations
About Hernandez Marlow
Hernandez Marlow is PDG and a director of Cano Health, Inc. (XNAS). The 17 filings recorded, over the period from 2021-08-18 to 2023-07-14, show purchases of EUR 2,019,903 and no sales, with the modal transaction nature listed as Attribution.
